Many people, scientists included, envision genomics research as a group of scientists busily working to locate and identify new genes and then, in the "Eureka!" moment, discovering one and rushing off to publish it in a paper or file it in a patent application. The problem with this picture is that it fails to recognize the IP treasures represented by everything that happens before the "Eureka!" moment. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.